{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_000315.1:c.1308G>A",
          "cDNA Change": {
            "transcript": "NM_000315.1",
            "ref": "G",
            "alt": "A",
            "position": "1308"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "437"
          },
          "Description in input context": "Nonsense mutation causing premature termination of translation, leading to loss of PINK1 protein function."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005123"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial respiratory function assay",
      "Material used": {
        "Material Source": "Human fibroblasts",
        "Material Name": "Patient-derived fibroblasts vs. normal fibroblasts",
        "Description": "Comparison of mitochondrial respiratory activity, respiratory control ratio, and ATP production between patient and normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000315.1:c.1308G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss of PINK1 protein function",
          "Result Description": "Significantly reduced mitochondrial respiratory activity (20% lower than controls), decreased respiratory control ratio (30% lower), and impaired ATP production via glycolysis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent patient samples and three normal fibroblast samples."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as positive control for respiratory function."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Control samples with no added substrate used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Respiratory control ratio ≥ 1.5 and mitochondrial respiration ≥ 50% of controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Respiratory control ratio ≤ 1.0 and mitochondrial respiration ≤ 30% of controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cytochrome c content measurement",
      "Material used": {
        "Material Source": "Mitochondrial fractions",
        "Material Name": "Patient-derived vs. normal fibroblasts",
        "Description": "Quantification of cytochrome c levels in mitochondrial fractions using Western blot."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000315.1:c.1308G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss of PINK1 protein function",
          "Result Description": "Cytochrome c levels reduced by 60% compared to normal fibroblasts, indicating impaired mitochondrial function."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent patient samples and three normal fibroblast samples."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as positive control for cytochrome c levels."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Control samples with no added substrate used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cytochrome c levels ≥ 80% of controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cytochrome c levels ≤ 50% of controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "ROS measurement",
      "Material used": {
        "Material Source": "Cell culture supernatants",
        "Material Name": "Patient-derived vs. normal fibroblasts",
        "Description": "Measurement of reactive oxygen species (ROS) levels using DCFH-DA fluorescence assay."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000315.1:c.1308G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss of PINK1 protein function",
          "Result Description": "ROS levels increased by 40% compared to normal fibroblasts, indicating oxidative stress."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent patient samples and three normal fibroblast samples."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as positive control for ROS levels."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Control samples with no added substrate used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ROS levels ≤ 20% of controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ROS levels ≥ 50% of controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}